WASHINGTON DC – United States federal authorities recommend this March “pause” the administration of the vaccine against coronavirus developed by Johnson & Johnson Pharmaceuticals to investigate potentially dangerous blood clots.
In a joint communication, the Centers for the Control and Prevention of Injuries (CDC, por sig siglas in English) and the Administration of Medicines and Food (FDA), which is investigating the detection of thrombi in six women and the following posterior in ‘n vacunación, combined with a reduced content of plaques.
Report of the report The New York Times, todas las mujeres afectadas tienen entre 18 y 48 años. A female failure and a second female Nebraska woman is hospitalized in serious condition.
In the EUEU he administered more than 6.8 million doses of the Johnson & Johnson vaccine, which is a single dose.
SEE THE VACUUM CENTER IN FEDERAL CENTERS IN THE UNITED STATES ANNUAL
Federal distribution channels, including the massive evacuation centers, will start using the pharmacy temporarily, and it is hoped that the states and other providers will do the same.
Other vacancies, the Modern and the Pfizer, include the vast majority of inoculations administered in the EU and are not affected by the break.
The Assessment Committee for the Practice of Immunization of the CDC is meeting the mercenaries to study the cases. The FDA initiated its own investigation.
“As soon as the process is complete, we recommend a break in the use of this vaccine by precaution”, said doctors Anne Schuchat, Deputy Director of the CDC, and Peter Marks, Director of the FDA’s Biological Evaluation and Research Center, in a communicated joint.
THE PELIGROS SYMPTOMS OF THE JOHNSON & JOHNSON VACUUM
The agencies recommend that women receive the Johnson & Johnson vaccine and have experienced cabbage paints, abdominal paints, piercing paints or failures to breathe three weeks after the injection of contact with their doctor.
The authorities say they want to train the car manufacturers and the health professionals about the “singular treatment” corresponding to these blood clots.
THE JOHNSON & JOHNSON RECEPTION ABOUT THE SANGUINE BULLS
Johnson & Johnson asserted that he was standing in front of the bullets, but insisted that he had not even established an angle with his car.
“We are engaged in thromboembolic events, including some with thrombocytopenia, have been reported in relation to the vaccines against COVID-19”, said the company in a statement. “Until now, we have not established a clear causal relationship between these unusual events and the vacancy,” he added.
Johnson & Johnson’s vacancy was authorized as an emergency response by the FDA to fines in February with a grand ceremony, in anticipation of which, requiring a single dose and conditions of relatively easy facilitation, would impede the entire vacation campaign. .
Without embarrassment, this vacancy constitutes a small percentage of the EU administrations, debits and errors in the plant of one of its counterparts in Baltimore.